1. Home
  2. DRUG vs BOW Comparison

DRUG vs BOW Comparison

Compare DRUG & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$60.45

Market Cap

778.4M

Sector

Health Care

ML Signal

N/A

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

N/A

Current Price

$33.77

Market Cap

734.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
DRUG
BOW
Founded
2019
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
778.4M
734.3M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
DRUG
BOW
Price
$60.45
$33.77
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$129.25
$32.29
AVG Volume (30 Days)
76.2K
323.9K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.26
EPS
N/A
0.96
Revenue
N/A
$551,589,000.00
Revenue This Year
N/A
$21.31
Revenue Next Year
N/A
$19.15
P/E Ratio
N/A
$35.13
Revenue Growth
N/A
29.58
52 Week Low
$44.25
$21.21
52 Week High
$123.75
$35.07

Technical Indicators

Market Signals
Indicator
DRUG
BOW
Relative Strength Index (RSI) 28.03 60.75
Support Level $56.47 $24.07
Resistance Level $78.35 $33.92
Average True Range (ATR) 2.92 0.11
MACD -1.28 -0.10
Stochastic Oscillator 4.75 51.28

Price Performance

Historical Comparison
DRUG
BOW

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: